AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 71 filers reported holding AVEO PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $562,000 | -47.1% | 669,449 | -30.1% | 0.03% | -58.2% |
| Q3 2014 | $1,063,000 | -51.6% | 958,026 | -20.2% | 0.08% | -51.8% |
| Q2 2014 | $2,197,000 | -48.6% | 1,200,800 | -58.0% | 0.16% | -7.3% |
| Q1 2014 | $4,274,000 | +63.4% | 2,858,348 | +100.0% | 0.18% | -27.5% |
| Q4 2013 | $2,615,000 | -63.8% | 1,429,174 | -59.3% | 0.24% | -67.8% |
| Q3 2013 | $7,229,000 | -17.6% | 3,509,205 | 0.0% | 0.76% | -26.8% |
| Q2 2013 | $8,773,000 | – | 3,509,205 | – | 1.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer VI & Co. LLC | 675,242 | $1,884,000 | 100.00% |
| Prosight Management, LP | 1,057,690 | $2,951,000 | 2.17% |
| NEA Management Company, LLC | 16,362,694 | $45,652,000 | 1.89% |
| EMORY UNIVERSITY | 602,883 | $1,682,000 | 1.44% |
| New Leaf Venture Partners, L.L.C. | 964,520 | $2,691,000 | 1.26% |
| RA Capital Management | 5,062,759 | $14,125,000 | 1.18% |
| Avoro Capital Advisors LLC | 4,006,893 | $11,179,000 | 0.72% |
| 683 Capital Management, LLC | 2,500,000 | $6,975,000 | 0.59% |
| X-Square Capital, LLC | 199,345 | $557,000 | 0.59% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,300,000 | $3,627,000 | 0.43% |